NCT00003945View on ClinicalTrials.gov

Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

January 31, 2007

Conditions
Cervical Cancer
Interventions
DRUG

cisplatin

DRUG

topotecan hydrochloride

Trial Locations (11)

34

Instituto de Enfermedades Neoplasicas, Lima

2145

Westmead Hospital, Westmead

50309

John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines

50314

Mercy Cancer Center at Mercy Medical Center-Des Moines, Des Moines

87131

MBCCOP - University of New Mexico HSC, Albuquerque

46202-5289

Indiana University Cancer Center, Indianapolis

50316-2301

Iowa Lutheran Hospital, Des Moines

68128-4157

Midlands Cancer Center at Midlands Community Hospital, Papillion

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

54307-3453

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

00936-7344

San Juan City Hospital, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Eastern Cooperative Oncology Group

NETWORK

lead

Gynecologic Oncology Group

NETWORK

NCT00003945 - Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer | Biotech Hunter | Biotech Hunter